What Should I Expect?

Xoft® electronic brachytherapy (eBx®) is administered under the direction of a radiation oncologist. The simple outpatient treatment regimen and prescription depend on tumor size, type, depth, patient age, prior treatments and other criteria. An individualized treatment plan with custom shielding is developed for each patient.

During radiation therapy, a small surface applicator is placed on the skin where the radiation is delivered. The treatment site can be prepared with a flexible shield to protect the adjacent non-target tissues. The miniaturized X-ray source is placed in the applicator and then attached to the Xoft controller to deliver radiation for the determined treatment time. The therapy is non-invasive and painless. At the completion of the treatment, the X-ray source is turned off, all devices are removed, and the patient is able to return to normal daily activities. Since Xoft eBx® is a superficial skin cancer treatment, there is no radiation exposure to other areas of your body.

Who are the Ideal Candidates for Radiation Treatment?

  • Patients who are not interested in having surgery. Patients with cosmetically sensitive lesions. Patients for whom restoration of larger lesions on lips or ears is difficult or impossible for necessary function (wearing glasses etc.); Patients who are not surgical candidates for medical reasons (e.g. blood thinning medication) Patients who require additional treatment for aggressive skin cancers following surgical treatment
  • Patients with positive margins after excision to reduce the risk of recurrence

See patient brochure for additional important information

References

1 American Cancer Society (2007 Statistics from the American Cancer Society), accessed February 9, 2009.

2 Chan S, Dhadda S, Swindell R: Single fraction radiotherapy for small carcinoma of the skin. Clinical Oncology 2007; 19: 256–259.

3 Barlow JO, Zalla MJ, Kyle A, DiCaudao DJ, Lim KK, Yiannias JA. Journal of the American Academy of Dermatology 2006; 54; 1034–1039.

4 The Skin Cancer Foundation (2008)

5 Cancer Therapy Evaluation Program (Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS. March 31, 2003), published August 9, 2006.

Quick Links

Candidates for
Skin eBx Treatment

Surgery is not the only option.

Electronic Brachytherapy (eBx) is a safe and effective non-surgical treatment for your non-melanoma skin cancer.

Click here to view a patient brochure.

©2017 Xoft®, a subsidiary of iCAD, Inc. All rights reserved. Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are registered trademarks of iCAD, Inc.

Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.